{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:50:06Z","timestamp":1775022606147,"version":"3.50.1"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Boron Neutron Capture Therapy (BNCT), often referred to as the \u2018cell knife,\u2019 represents a binary, tumor-selective therapeutic modality that minimizes damage to surrounding healthy tissues. This review provides a comprehensive clinical perspective on BNCT, addressing the radiobiological mechanisms and summarizing related clinical trials, with a particular emphasis on glioma and head and neck cancers. Furthermore, the paper touches upon the synergistic potential of BNCT when integrated with other treatment modalities, such as proton and carbon ion radiotherapy, alternative neutron capture therapies, ultrasound, and immunotherapy. These combined approaches may offer promising avenues for future research, potentially enhancing the therapeutic index and expanding the applicability of BNCT in oncological practice.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1536355","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:10:25Z","timestamp":1744863025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["\u2018Cell knife\u2019 for cancer: the clinician\u2019s perspective"],"prefix":"10.3389","volume":"16","author":[{"given":"Zihan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongdan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenfang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12089","article-title":"Boron neutron capture therapy: Current status and future perspectives","volume":"40","author":"Dymova","year":"2020","journal-title":"Cancer Commun (London England)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/cancers12051334","article-title":"Boron neutron capture therapy and photodynamic therapy for high-grade meningiomas","volume":"12","author":"Nakahara","year":"2020","journal-title":"Cancers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"109222","DOI":"10.1016\/j.apradiso.2020.109222","article-title":"Verification for dose estimation performance of a Monte-Carlo based treatment planning system in University of Tsukuba","volume":"166","author":"Kumada","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"B6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13014-021-01968-2","article-title":"Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system","volume":"16","author":"Hu","year":"2021","journal-title":"Radiat Oncol (London England)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21037\/tro.2018.10.12","article-title":"Treatment planning system and patient positioning for boron neutron capture therapy","volume":"2","author":"Kumada","year":"2018","journal-title":"Ther Radiol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rru109","article-title":"Estimation of relative biological effectiveness for boron neutron capture therapy using the PHITS code coupled with a microdosimetric kinetic model","volume":"56","author":"Horiguchi","year":"2015","journal-title":"J Radiat Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/3579742","article-title":"The radiation biology of boron neutron capture therapy","volume":"151","author":"Coderre","year":"1999","journal-title":"Radiat Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/2193-1801-3-128","article-title":"The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy","volume":"3","author":"Masunaga","year":"2014","journal-title":"SpringerPlus"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2015.08.001","article-title":"Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells","volume":"106","author":"Sato","year":"2015","journal-title":"Appl Radiat Isot"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00411-017-0729-y","article-title":"In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line","volume":"57","author":"Rodriguez","year":"2018","journal-title":"Radiat Environ Biophys"},{"key":"B13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/genes14010127","article-title":"DNA damage response and repair in boron neutron capture therapy","volume":"14","author":"Mechetin","year":"2023","journal-title":"Genes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2020.4","article-title":"The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma","volume":"22","author":"Zhou","year":"2020","journal-title":"Expert Rev Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3504","article-title":"Effects of carbon ion irradiation and X-ray irradiation on the ubiquitylated protein accumulation","volume":"49","author":"Isozaki","year":"2016","journal-title":"Int J Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1038\/s41467-019-12226-1","article-title":"The EYA3 tyrosine phosphatase activity promotes pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2014.03.003","article-title":"Histological and biochemical analysis of DNA damage after BNCT in rat model","volume":"88","author":"Masutani","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"B18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1748-717X-4-63","article-title":"Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma","volume":"4","author":"Fujita","year":"2009","journal-title":"Radiat Oncol (London England)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso","article-title":"Detection of DNA double-strand breaks in boron neutron capture reaction","volume":"106","author":"Okamoto","year":"2015","journal-title":"Appl Radiat Isot"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.676575","article-title":"Molecular mechanisms of specific cellular DNA damage response and repair induced by the mixed radiation field during boron neutron capture therapy","volume":"11","author":"Maliszewska-Olejniczak","year":"2021","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11499","article-title":"DNA double-strand breaks induced byFractionated neutron beam irradiation for boron neutron capture therapy","volume":"37","author":"Kinashi","year":"2017","journal-title":"Anticancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.02.030","article-title":"Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer","volume":"69","author":"Dagrosa","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.07.020","article-title":"First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line","volume":"79","author":"Dagrosa","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B24","doi-asserted-by":"publisher","first-page":"201367","DOI":"10.4061\/2010\/201367","article-title":"Cellular responses to Cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J Nucleic Acids"},{"key":"B25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00411-015-0625-2","article-title":"DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV","volume":"55","author":"Kondo","year":"2016","journal-title":"Radiat Environ Biophys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.03.044","article-title":"In vitro studies of cellular response to DNA damage induced by boron neutron capture therapy","volume":"69","author":"Perona","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13881","article-title":"Analysis of DNA damage responses after boric acid-mediated boron neutron capture therapy in hepatocellular carcinoma","volume":"39","author":"Chen","year":"2019","journal-title":"Anticancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/09553002.2011.530336","article-title":"Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy","volume":"87","author":"Fujita","year":"2011","journal-title":"Int J Radiat Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81684-0","article-title":"A long twentieth century of the cell cycle and beyond","volume":"100","author":"Nurse","year":"2000","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109929200","article-title":"Ubiquitin\/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest","volume":"277","author":"Hu","year":"2002","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1748-717X-8-195","article-title":"Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem\/progenitor cells in vitro","volume":"8","author":"Sun","year":"2013","journal-title":"Radiat Oncol (London England)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/09553000801902125","article-title":"Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells","volume":"84","author":"Kamida","year":"2008","journal-title":"Int J Radiat Biol"},{"key":"B33","article-title":"Influence of p53 status on the effects of boron neutron capture therapy in glioblastoma","volume":"35","author":"Seki","year":"2015","journal-title":"Anticancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/1471-2407-10-661","article-title":"Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2\/Bax","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2008.00720.x","article-title":"Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model","volume":"38","author":"Aromando","year":"2009","journal-title":"J  Pathol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00380-4","article-title":"Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy","volume":"187","author":"Yoshida","year":"2002","journal-title":"Cancer Lett"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2019.1666214","article-title":"Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential","volume":"95","author":"Masunaga","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1269\/jrr.43.11","article-title":"Significance of the response of quiescent cell populations within solid tumors in cancer therapy","volume":"43","author":"Masunaga","year":"2002","journal-title":"J Radiat Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa024","article-title":"YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells","volume":"61","author":"Harada","year":"2020","journal-title":"J Radiat Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2021.1956004","article-title":"HIF-1\u03b1 affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA","volume":"97","author":"Sanada","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2408-x","article-title":"Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1(R132H) mutation-negative glioblastoma","volume":"133","author":"Kondo","year":"2017","journal-title":"J Neuro-oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e59639","DOI":"10.1371\/journal.pone.0059639","article-title":"Apoptosis through Bcl-2\/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy","volume":"8","author":"Fai\u00e3o-Flores","year":"2013","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.601820","article-title":"Boron neutron capture therapy: A review of clinical applications","volume":"11","author":"Malouff","year":"2021","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/BF02699937","article-title":"Assessment of the results from the phase I\/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician\u2019s point of view","volume":"62","author":"Diaz","year":"2003","journal-title":"J Neuro-oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00891-2","article-title":"Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory","volume":"40","author":"Chadha","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)02862-6","article-title":"Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy","volume":"53","author":"Palmer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2004.05.008","article-title":"Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam","volume":"61","author":"Kiger","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.06.008","article-title":"Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961","volume":"61","author":"Vos","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/BF02699941","article-title":"Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial","volume":"62","author":"Hidegh\u00e9ty","year":"2003","journal-title":"J Neuro-oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/BF03038906","article-title":"Organisation and management of the first clinical trial of BNCT in Europe (EORTC protocol 11961).EORTC BNCT study group","author":"Sauerwein","year":"1999","journal-title":"Strahlenther und Onkol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF02699939","article-title":"Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine","volume":"62","author":"Joensuu","year":"2003","journal-title":"J Neuro-oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.02.031","article-title":"L-boronophenylalanine-mediated boron neutron capture therapy for Malignant glioma progressing after external beam radiation therapy: a Phase I study","volume":"80","author":"Kankaanranta","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.04.015","article-title":"Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)","volume":"88","author":"Henriksson","year":"2008","journal-title":"Radiother Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00924.x","article-title":"An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme","volume":"117","author":"Pellettieri","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.03.016","article-title":"Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with Malignant glioma-correlation between radiation dose and radiation injury and clinical outcome","volume":"65","author":"Kageji","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.05.029","article-title":"Clinical results of boron neutron capture therapy (BNCT) for glioblastoma","volume":"69","author":"Kageji","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.03.021","article-title":"Long-survivors of glioblatoma treated with boron neutron capture therapy (BNCT)","volume":"69","author":"Kageji","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2004.05.010","article-title":"Current clinical results of the Tsukuba BNCT trial","volume":"61","author":"Yamamoto","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.02.009","article-title":"Boron neutron capture therapy for newly diagnosed glioblastoma","volume":"91","author":"Yamamoto","year":"2009","journal-title":"Radiother Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.103.6.1000","article-title":"Modified boron neutron capture therapy for Malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages","volume":"103","author":"Miyatake","year":"2005","journal-title":"J Neurosurg"},{"key":"B61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1269\/jrr.08043","article-title":"Boron neutron capture therapy for newly diagnosed glioblastoma","volume":"50","author":"Kawabata","year":"2009","journal-title":"J Radiat Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-008-9699-x","article-title":"Survival benefit of Boron neutron capture therapy for recurrent Malignant gliomas","volume":"91","author":"Miyatake","year":"2009","journal-title":"J Neuro-oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.03.014","article-title":"Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy\/temozolomide in patients with newly diagnosed glioblastoma multiforme\u2013study design and current status report","volume":"69","author":"Kawabata","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyac004","article-title":"Boron neutron capture therapy and add-on bevacizumab in patients with recurrent Malignant glioma","volume":"52","author":"Furuse","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.oa.2018-0111","article-title":"Boron neutron capture therapy combined with early successive bevacizumab treatments for recurrent Malignant gliomas - A pilot study","volume":"58","author":"Shiba","year":"2018","journal-title":"Neurol Medico-chir"},{"key":"B66","doi-asserted-by":"publisher","first-page":"15_suppl","DOI":"10.1200\/JCO.2020.38.15_suppl.2536","article-title":"Accelerator-based BNCT in rescue treatment of patients with recurrent GBM: A multicenter phase II study","volume":"38","author":"Miyatake","year":"2020","journal-title":"J Clin Oncol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.03.039","article-title":"Boron neutron capture therapy in the treatment of locally recurred head and neck cancer","volume":"69","author":"Kankaanranta","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.09.057","article-title":"Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I\/II trial","volume":"82","author":"Kankaanranta","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.03.016","article-title":"Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy","volume":"72","author":"Kouri","year":"2004","journal-title":"Radiother Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.11.010","article-title":"Boron neutron capture therapy in the treatment of recurrent laryngeal cancer","volume":"95","author":"Haapaniemi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00856.x","article-title":"EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research\/phase 1 trial","volume":"13","author":"Wittig","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v122:5","article-title":"Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001)","volume":"122","author":"Wittig","year":"2008","journal-title":"Int J Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2004.05.059","article-title":"Effectiveness of BNCT for recurrent head and neck Malignancies","volume":"61","author":"Kato","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2009.03.103","article-title":"Effectiveness of boron neutron capture therapy for recurrent head and neck Malignancies","volume":"67","author":"Kato","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrt098","article-title":"Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer","volume":"55","author":"Suzuki","year":"2014","journal-title":"J Radiat Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-013-0580-3","article-title":"Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck","volume":"19","author":"Aihara","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2014.04.007","article-title":"BNCT for advanced or recurrent head and neck cancer","volume":"88","author":"Aihara","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2009.03.019","article-title":"Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node","volume":"67","author":"Kimura","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"B79","doi-asserted-by":"publisher","first-page":"15_suppl","DOI":"10.1200\/jco.2014.32.15_suppl.6046","article-title":"Boron neutron capture therapy in patients with recurrent head and neck cancers who have no other treatment options","volume":"32","author":"Kato","year":"2014","journal-title":"J Clin Oncol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13014-017-0949-y","article-title":"Dynamic changes in (18)F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and Malignant melanoma during boron neutron capture therapy patient selection","volume":"13","author":"Morita","year":"2018","journal-title":"Radiat Oncol (London England)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.03.041","article-title":"Clinical results and prognostic factors in boron neutron capture therapy for recurrent squamous cell carcinoma of the head and neck under the Japan national health insurance system: A retrospective study of the initial 47 patients","volume":"120","author":"Hirose","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B83","doi-asserted-by":"publisher","first-page":"110382","DOI":"10.1016\/j.radonc.2024.110382","article-title":"Efficacy and safety of boron neutron capture therapy for Hypopharyngeal\/Laryngeal cancer patients with previous head and neck irradiation","volume":"198","author":"Sato","year":"2024","journal-title":"Radiother Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2013.11.134","article-title":"Fractionated BNCT for locally recurrent head and neck cancer: experience from a phase I\/II clinical trial at Tsing Hua Open-Pool Reactor","volume":"88","author":"Wang","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"B85","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijrobp.2016.02.028","article-title":"Fractionated boron neutron capture therapy in locally recurrent head and neck cancer: A prospective phase I\/II trial","volume":"95","author":"Wang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0210626","DOI":"10.1371\/journal.pone.0210626","article-title":"A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer","volume":"14","author":"Lee","year":"2019","journal-title":"PloS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/cancers15102762","article-title":"Boron neutron capture therapy followed by image-guided intensity-modulated radiotherapy for locally recurrent head and neck cancer: A prospective phase I\/II trial","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e1382790","DOI":"10.1080\/2162402X.2017.1382790","article-title":"Glioma-induced SIRT1-dependent activation of hMOF histone H4 lysine 16 acetyltransferase in microglia promotes a tumor supporting phenotype","volume":"7","author":"Saidi","year":"2018","journal-title":"Oncoimmunology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"102029","DOI":"10.1016\/j.ctrv.2020.102029","article-title":"How did lomustine become standard of care in recurrent glioblastoma","volume":"87","author":"Weller","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)90036-0","article-title":"The fallacy of the localized supratentorial Malignant glioma","volume":"15","author":"Halperin","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90944-D","article-title":"National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma","volume":"30","author":"Sullivan","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195112062452301","article-title":"The uses of nuclear disintegration in the diagnosis and treatment of brain tumor","volume":"245","author":"Sweet","year":"1951","journal-title":"New Engl J Med"},{"key":"B94","article-title":"Neutron capture therapy with boron in the treatment of glioblastoma multiforme","volume":"71","author":"Farr","year":"1954","journal-title":"Am J Roentgenol Radium Ther Nuclear Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.11.4020","article-title":"Central nervous system radiation syndrome in mice from preferential 10B(n, alpha)7Li irradiation of brain vasculature","volume":"85","author":"Slatkin","year":"1988","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"B96","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/A:1005752827194","article-title":"Early history of development of boron neutron capture therapy of tumors","volume":"33","author":"Sweet","year":"1997","journal-title":"J Neuro-oncol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00005072-197204000-00005","article-title":"Neuropathologic study of fourteen cases of Malignant brain tumor treated by boron-10 slow neutron capture radiation","volume":"31","author":"Asbury","year":"1972","journal-title":"J Neuropathol Exp Neurol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1955)8:3<601::aid-cncr2820080326>3.0.co;2-r","article-title":"Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10","volume":"8","author":"Goodwin","year":"1955","journal-title":"Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/114.4.1609","article-title":"A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit","volume":"114","author":"Slatkin","year":"1991","journal-title":"Brain"},{"key":"B100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4684-5802-2_2","article-title":"Clinical results of boron neutron capture therapy","volume":"54","author":"Hatanaka","year":"1990","journal-title":"Basic Life Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)90479-0","article-title":"Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy","volume":"28","author":"Hatanaka","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl J Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.03.022","article-title":"Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential","volume":"69","author":"Hopewell","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2013.11.092","article-title":"Case numbers for a randomized clinical trial of boron neutron capture therapy for Glioblastoma multiforme","volume":"88","author":"Sander","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"B105","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13014-021-01939-7","article-title":"The basis and advances in clinical application of boron neutron capture therapy","volume":"16","author":"He","year":"2021","journal-title":"Radiat Oncol (London England)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"223507","DOI":"10.1063\/1.4903345","article-title":"Application of proton boron fusion reaction to radiation therapy: A Monte Carlo simulation study","volume":"105","author":"Yoon DK","year":"2014","journal-title":"Appl Phys Lett"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41598-018-19258-5","article-title":"First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness","volume":"8","author":"Cirrone","year":"2018","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/nano13152167","article-title":"Boron nanoparticle-enhanced proton therapy for cancer treatment","volume":"13","author":"Zavestovskaya","year":"2023","journal-title":"Nanomater (Basel Switzerland)"},{"key":"B109","doi-asserted-by":"publisher","first-page":"19264","DOI":"10.1038\/s41598-024-69370-y","article-title":"First independent validation of the proton-boron capture therapy concept","volume":"14","author":"Jel\u00ednek Michaelidesov\u00e1","year":"2024","journal-title":"Sci Rep"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/mp.15824","article-title":"Effect of boron compounds on the biological effectiveness of proton therapy","volume":"49","author":"Manandhar","year":"2022","journal-title":"Med Phys"},{"key":"B111","doi-asserted-by":"publisher","first-page":"096702","DOI":"10.1088\/0034-4885\/79\/9\/096702","article-title":"Nuclear physics in particle therapy: a review","volume":"79","author":"Durante","year":"2016","journal-title":"Rep Prog Phys"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad120f","article-title":"Combined BNCT-CIRT treatment planning for glioblastoma using the effect-based optimization","volume":"69","author":"Han","year":"2023","journal-title":"Phys Med Biol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e14399","DOI":"10.1002\/acm2.14399","article-title":"DNA-damage RBE assessment for combined boron and gadolinium neutron capture therapy","volume":"25","author":"Shamsabadi","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"B114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dnarep.2012.10.008","article-title":"Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining","volume":"12","author":"Bergs","year":"2013","journal-title":"DNA Repair"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2018.12.007","article-title":"Ultrasound hyperthermia technology for radiosensitization","volume":"45","author":"Zhu","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1159\/000492263","article-title":"Ultrasound-stimulated microbubbles enhance radiosensitization of nasopharyngeal carcinoma","volume":"48","author":"Deng","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S31564","article-title":"Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment","volume":"7","author":"Ibsen","year":"2013","journal-title":"Drug Design Dev Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2202001804","article-title":"Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits","volume":"220","author":"Hynynen","year":"2001","journal-title":"Radiology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e0166061","DOI":"10.1371\/journal.pone.0166061","article-title":"Effects on P-glycoprotein expression after blood-brain barrier disruption using focused ultrasound and microbubbles","volume":"12","author":"Aryal","year":"2017","journal-title":"PloS One"},{"key":"B120","doi-asserted-by":"publisher","first-page":"11222","DOI":"10.3390\/ijms231911222","article-title":"Landscape of cellular bioeffects triggered by ultrasound-induced sonoporation","volume":"23","author":"Przystupski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"216268","DOI":"10.1016\/j.canlet.2023.216268","article-title":"Particle radiotherapy in the era of radioimmunotherapy","volume":"567","author":"Zhou","year":"2023","journal-title":"Cancer Lett"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006409721365","article-title":"The combination of boron neutron-capture therapy and immunoprophylaxis for advanced intracerebral gliosarcomas in rats","volume":"46","author":"Smilowitz","year":"2000","journal-title":"J Neuro-oncol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e0222022","DOI":"10.1371\/journal.pone.0222022","article-title":"BNCT induced immunomodulatory effects contribute to mammary tumor inhibition","volume":"14","author":"Khan","year":"2019","journal-title":"PloS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12951-022-01304-0","article-title":"Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma","volume":"20","author":"Chen","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/s41467-023-37253-x","article-title":"Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy","volume":"14","author":"Shi","year":"2023","journal-title":"Nat Commun"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16294","article-title":"Carcinogenesis observed in the spleens of balb\/c mice after head-neutron irradiation","volume":"43","author":"Kinashi","year":"2023","journal-title":"Anticancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1263873","article-title":"Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model","volume":"13","author":"Chang","year":"2023","journal-title":"Front Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/life13071538","article-title":"Therapeutic efficacy, radiotoxicity and abscopal effect of BNCT at the RA-3 nuclear reactor employing oligo-fucoidan and glutamine as adjuvants in an ectopic colon cancer model in rats","volume":"13","author":"Frydryk Benitez","year":"2023","journal-title":"Life (Basel Switzerland)"},{"key":"B129","doi-asserted-by":"publisher","first-page":"0040","DOI":"10.34133\/bmr.0040","article-title":"Enhancing cancer therapy: boron-rich polyboronate ester micelles for synergistic boron neutron capture therapy and PD-1\/PD-L1 checkpoint blockade","volume":"28","author":"Chiu","year":"2024","journal-title":"Biomater Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e2405158","DOI":"10.1002\/advs.202405158","article-title":"Boron neutron capture therapy-derived extracellular vesicles via DNA accumulation boost antitumor dendritic cell vaccine efficacy","volume":"11","author":"Lv","year":"2024","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/cas.v115.10","article-title":"Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)","volume":"115","author":"Fujimoto","year":"2024","journal-title":"Cancer Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00602.x","article-title":"Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells","volume":"222","author":"Marigo","year":"2008","journal-title":"Immunol Rev"},{"key":"B133","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13071-018-2905-6","article-title":"Microarray analysis of long non-coding RNA expression profiles in monocytic myeloid-derived suppressor cells in Echinococcus granulosus-infected mice","volume":"11","author":"Yu","year":"2018","journal-title":"Parasit Vectors"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1536355\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:10:26Z","timestamp":1744863026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1536355\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":133,"alternative-id":["10.3389\/fimmu.2025.1536355"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1536355","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"article-number":"1536355"}}